Insights

Clinical trial efficiency Nilogen’s preclinical testing platforms using fresh patient tumor samples with intact tumor immune microenvironment aim to reduce cost and risk in clinical trials, presenting a sales angle around accelerating immuno-oncology programs and lowering development risk for sponsors.

Immuno-oncology focus With emphasis on cancer and immuno-oncology drug development and translational platform support, there are opportunities to partner with pharma and biotech companies pursuing IO therapies seeking clinically relevant preclinical-to-clinical bridging data.

Strategic partnerships Recent collaborations with Scailyte and Eolas Biosciences indicate an openness to co-developing or expanding networks in key markets like Japan and broader translational platforms, suggesting potential for channel partnerships and joint opportunities.

Growing footprint Revenue is in the multi‑million range with a small to mid-size employee base, signaling a nimble organization likely seeking scalable, high‑value contracts and repeat business from biotechs and mid‑tier pharma companies.

Global expansion potential Leadership hires in business development roles and a global client base imply readiness to scale client acquisition; target conversations can focus on expanding access to Nilogen’s translational platforms in established markets and new regions, including Asia-Pacific.

Similar companies to Nilogen Oncosystems

Nilogen Oncosystems Tech Stack

Nilogen Oncosystems uses 8 technology products and services including LinkedIn Ads, Drupal, Zoho, and more. Explore Nilogen Oncosystems's tech stack below.

Nilogen Oncosystems's Email Address Formats

Nilogen Oncosystems uses at least 2 email formats:
Nilogen Oncosystems Email FormatsExamplePercentage
FirstL@nilogen.comJohnD@nilogen.com
60%
First@nilogen.comJohn@nilogen.com
40%

Frequently Asked Questions

What is Nilogen Oncosystems's phone number?

Minus sign iconPlus sign icon
You can contact Nilogen Oncosystems's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Nilogen Oncosystems's official website and social media links?

Minus sign iconPlus sign icon
Nilogen Oncosystems's official website is nilogen.com and has social profiles on LinkedIn.

How much revenue does Nilogen Oncosystems generate?

Minus sign iconPlus sign icon
As of October 2026, Nilogen Oncosystems's annual revenue is estimated to be $10M - $25M.

What is Nilogen Oncosystems's SIC code and NAICS code?

Minus sign iconPlus sign icon
Nilogen Oncosystems's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nilogen Oncosystems have currently?

Minus sign iconPlus sign icon
As of October 2026, Nilogen Oncosystems has approximately 17 employees across 2 continents, including North America and Europe. Key team members include Director: E. D., Director: L. L. M. and Director: P. L. M. Explore Nilogen Oncosystems's employee directory with LeadIQ.

What industry does Nilogen Oncosystems belong to?

Minus sign iconPlus sign icon
Nilogen Oncosystems operates in the Biotechnology Research industry.

What technology does Nilogen Oncosystems use?

Minus sign iconPlus sign icon
Nilogen Oncosystems's tech stack includes LinkedIn Ads, Drupal, Zoho, Shopify, Microsoft 365, Google Cloud, Piwik and Piwik PRO Core.

What is Nilogen Oncosystems's email format?

Minus sign iconPlus sign icon
Nilogen Oncosystems's email format typically follows the pattern of FirstL@nilogen.com. Find more Nilogen Oncosystems email formats with LeadIQ.

When was Nilogen Oncosystems founded?

Minus sign iconPlus sign icon
Nilogen Oncosystems was founded in 2013.
Nilogen Oncosystems logo

Nilogen Oncosystems

Biotechnology ResearchFlorida, United States11-50 Employees

Nilogen Oncosystems is a biotechnology research company based at 3802 Spectrum Boulevard #207 in Tampa, Florida. It develops preclinical drug testing platforms that use fresh patient tumor samples with an intact tumor immune microenvironment to illuminate the molecular mechanisms underlying drug sensitivity and resistance. The platforms are designed to reduce the cost and risk associated with clinical trials by enabling testing and customization of cancer therapies. The company has pursued strategic partnerships, including a collaboration with Scailyte AG announced in 2022 and a partnership with Eolas Biosciences Co. Ltd. in 2021. Nilogen reports a workforce of 11 to 50 employees and a revenue range of $10 million to $25 million.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
11-50

Section iconFunding & Financials

  • $10M - $25M

    Nilogen Oncosystems's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.